Skip to content

To investigate the impact of vitamin D supplements on complications and duration of stay in patients in need of immediate abdominal surgery

Effect of Vitamin D Supplementation on Pro-inflammatory, Anti-inflammatory Markers and Perioperative outcomes in Patients Undergoing Emergency LAParotomy (VD-LAP): A Randomized Controlled Pilot Study. - VD-LAP

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/06/088304
Enrollment
50
Registered
2025-06-05
Start date
Unknown
Completion date
Unknown
Last updated
2025-06-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: K928- Other specified diseases of the digestive system

Interventions

Intervention1: Vitamin D (Arachitol): Injection Vitamin D (Arachitol) Dose: 0.5ml containing 3,00,000 IU. Duration: Single dose. Route of administration: Intramuscular in deltoid muscle. Timing: Be

Sponsors

AIIMS Mangalagiri
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patients scheduled for emergency laparotomy (e.g., for bowel obstruction, perforation, ischemia, or any acute abdomen requiring emergency midline laparotomy) Surgery planned within 24 hours of admission

Exclusion criteria

Exclusion criteria: Patients with a known history of primary hyperparathyroidism Severe comorbidities (end-stage renal disease, active malignancy, severe hepatic impairment) Use of immunosuppressive medications or corticosteroids Pregnancy or breastfeeding.

Design outcomes

Primary

MeasureTime frame
Change in plasma levels of pro-inflammatory markers (IL-6, CRP) and anti-inflammatory marker (IL-10)Timepoint: 0 hours, 24-hours, 72-hours

Secondary

MeasureTime frame
1. Feasibility Proportion of eligible patients recruited and completing the protocol, timing of administration of Vitamin D after randomization before laparotomy.Timepoint: 0 hours;2. Safety hypercalcemia (serum calcium, phosphorus)Timepoint: 0 hours, 24-hours, 72-hours;3. Post-operative outcome- a. Length of ICU stay, length of hospital stays.Timepoint: 30 days;3. Post-operative outcome- b. New onset organ dysfunction, worsening of pre-operative acute organ dysfunctionTimepoint: 30 days;3. Post-operative outcome- c. Requirement of organ support (mechanical ventilation-duration/days, dialysis-number of sessions, number of blood transfusions, cardiac support-inotropes- number, duration/days, requirement of total parenteral nutrition).Timepoint: 30 days;3. Post-operative outcome- d. Post-operative systemic complications Cardiac- arrythmias, respiratory-pneumonia, pleural effusion, renal- acute renal failure, jaundice, thrombocytopenia.Timepoint: 30 days;3. Post-operative outcome- e. Post-operative regional complications (abdomen) intra-abdominal collection, paralytic ileus, othersTimepoint: 30 days;3. Post-operative outcome - f. Post-operative surgical site complications surgical site infection as per CDC criteria, seroma, hematoma, wound dehiscence, others.Timepoint: 30 days;3. Post-operative outcome- g. Clavien-Dindo grading of post-operative complications.Timepoint: 30 days;3. Post-operative outcome- h. Survival till 30 daysTimepoint: 30 days;4.To explore potential associations between baseline vitamin D levels and inflammatory responses i.e., subgroup analysis between baseline low vitamin D and normal vitamin D level patients.Timepoint: 0 hours, 24-hours, 72-hours

Countries

India

Contacts

Public ContactDr Mallikarjun Gunjiganvi

AIIMS Mangalagiri

gunjiganvi@gmail.com08860801346

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026